Connect Biopharma Holdings Stock Alpha and Beta Analysis
| CNTB Stock | USD 1.03 0.06 6.19% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Connect Biopharma Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in Connect Biopharma over a specified time horizon. Remember, high Connect Biopharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Connect Biopharma's market risk premium analysis include:
Beta 1.92 | Alpha 0.057 | Risk 5.47 | Sharpe Ratio (0.1) | Expected Return (0.54) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Connect |
Connect Biopharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Connect Biopharma market risk premium is the additional return an investor will receive from holding Connect Biopharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Connect Biopharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Connect Biopharma's performance over market.| α | 0.06 | β | 1.92 |
Connect Biopharma expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Connect Biopharma's Buy-and-hold return. Our buy-and-hold chart shows how Connect Biopharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Connect Biopharma Market Price Analysis
Market price analysis indicators help investors to evaluate how Connect Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Connect Biopharma shares will generate the highest return on investment. By understating and applying Connect Biopharma stock market price indicators, traders can identify Connect Biopharma position entry and exit signals to maximize returns.
Connect Biopharma Return and Market Media
The median price of Connect Biopharma for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 is 1.23 with a coefficient of variation of 11.3. The daily time series for the period is distributed with a sample standard deviation of 0.14, arithmetic mean of 1.21, and mean deviation of 0.1. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Connect Biopharma shares hold at Buy after FDA meeting By Investing.com - Investing.com Canada | 09/06/2024 |
2 | Connect Biopharma Holdings Limited Short Interest Up 76.0 percent in August - MarketBeat | 09/13/2024 |
3 | CNTB Stock Surges Over 5 percent Amid Strong Financial Performance | 10/02/2024 |
4 | Conduit Pharmaceuticals Stock Surges Amid Positive Earnings Report | 10/14/2024 |
5 | CNTB Stock Surges Amid Positive Earnings and Strong Buy Ratings | 11/27/2024 |
About Connect Biopharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Connect or other stocks. Alpha measures the amount that position in Connect Biopharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 (projected) | Net Debt To EBITDA | 0.72 | 1.81 | 1.53 | Intangibles To Total Assets | 0.0182 | 4.92E-4 | 4.68E-4 |
Connect Biopharma Upcoming Company Events
As portrayed in its financial statements, the presentation of Connect Biopharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Connect Biopharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Connect Biopharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Connect Biopharma. Please utilize our Beneish M Score to check the likelihood of Connect Biopharma's management manipulating its earnings.
| 9th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 9th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Connect Biopharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Connect Biopharma Backtesting, Connect Biopharma Valuation, Connect Biopharma Correlation, Connect Biopharma Hype Analysis, Connect Biopharma Volatility, Connect Biopharma History and analyze Connect Biopharma Performance. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Connect Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.